IDH2 and cancer: No mutations were detected at hotspot mutation regions in 11 oncogenes frequently mutated in human cancer (AKT, MET, PIK3CA, KRAS, NRAS, IDH1, IDH2, NOTCH, SMO, ABL, and EGFR).